GlassScriptPhysician profile
Nichelle Warren
NPI 1760869051
$6,763.60
in general payments reported to CMS, 2019-2025
28 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $165 · 2021: $792 · 2022: $996 · 2023: $2,360 · 2024: $762 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,579 · Travel and Lodging: $766 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.00 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,578.78 |
| Travel and Lodging | $766.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,403.75 | 2021-2023 | |
| Mallinckrodt Hospital Products INC. | $703.56 | 2021-2025 | Acthar |
| Glaukos Corporation | $694.50 | 2019-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Oyster Point Pharma, INC. | $636.11 | 2022-2025 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $606.93 | 2019-2025 | Rocklatan, Simbrinza, Tryptyr |
| Harrow Eye, LLC | $400.55 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $335.55 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Johnson & Johnson Surgical Vision, INC. | $305.74 | 2019-2025 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $194.48 | 2021-2023 | Cequa |
| Rxsight INC | $190.40 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $162.88 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $150.40 | 2021-2025 | Oxervate |
| Abbvie INC. | $140.71 | 2024-2025 | |
| Amgen INC. | $131.95 | 2024-2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $127.98 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $118.23 | 2019 | |
| Ani Pharmaceuticals, INC. | $84.82 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $75.15 | 2021-2023 | |
| Rayner Intraocular Lenses Limited | $53.18 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Spheric |
| Aerie Pharmaceuticals, INC. | $45.98 | 2019-2021 | |
| Ocular Therapeutix, INC. | $32.73 | 2021-2025 | Dextenza |
| Thea Pharma INC. | $31.23 | 2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.05 | 2019 | |
| Allergan, INC. | $27.30 | 2020 | |
| Alimera Sciences, INC. | $25.67 | 2024 | Iluvien, Yutiq |
| Becton, Dickinson and Company | $25.00 | 2024 | |
| Kala Pharmaceuticals, INC. | $15.79 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nichelle Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.